Rudulier CD - Search Results

1

Treatment with anti-cytokine monoclonal antibodies can potentiate the target cytokine rather than neutralize its activity.

Rudulier CD, Larché M, Moldaver D. Rudulier CD, et al. Allergy. 2016 Mar;71(3):283-5. doi: 10.1111/all.12816. Allergy. 2016. PMID: 26619376 No abstract available.

2

Peptide Immunotherapy; short but long lasting?

Simms EJ, Syed I, Rudulier C, Larché M. Simms EJ, et al. Curr Treat Options Allergy. 2015;2(1):64-71. doi: 10.1007/s40521-014-0043-8. Epub 2015 Feb 3. Curr Treat Options Allergy. 2015. PMID: 32953388 Free PMC article.

3

An Update on Lymphocyte Subtypes in Asthma and Airway Disease.

Moldaver DM, Larché M, Rudulier CD. Moldaver DM, et al. Among authors: rudulier cd. Chest. 2017 May;151(5):1122-1130. doi: 10.1016/j.chest.2016.10.038. Epub 2016 Nov 3. Chest. 2017. PMID: 27818326 Free PMC article. Review.

4

Induction of bystander tolerance and immune deviation after Fel d 1 peptide immunotherapy.

Moldaver DM, Bharhani MS, Rudulier CD, Wattie J, Inman MD, Larché M. Moldaver DM, et al. Among authors: rudulier cd. J Allergy Clin Immunol. 2019 Mar;143(3):1087-1099.e4. doi: 10.1016/j.jaci.2018.03.023. Epub 2018 Jun 12. J Allergy Clin Immunol. 2019. PMID: 29906527

5

Modulation of CRTh2 expression on allergen-specific T cells following peptide immunotherapy.

Rudulier CD, Tonti E, James E, Kwok WW, Larché M. Rudulier CD, et al. Allergy. 2019 Nov;74(11):2157-2166. doi: 10.1111/all.13867. Epub 2019 Jun 7. Allergy. 2019. PMID: 31077596 Free PMC article.

6

Antigen presenting B cells facilitate CD4 T cell cooperation resulting in enhanced generation of effector and memory CD4 T cells.

Kroeger DR, Rudulier CD, Bretscher PA. Kroeger DR, et al. Among authors: rudulier cd. PLoS One. 2013 Oct 14;8(10):e77346. doi: 10.1371/journal.pone.0077346. eCollection 2013. PLoS One. 2013. PMID: 24155947 Free PMC article.

7

The activation, by antigen, of naïve TCR transgenic CD4 T cells cultured at physiological, rather than artificially high, frequencies more accurately reflects the in vivo activation of normal numbers of naïve CD4(+) T cells.

Rudulier CD, Kroeger DR, Bretscher PA. Rudulier CD, et al. Cell Immunol. 2012;274(1-2):115-20. doi: 10.1016/j.cellimm.2012.01.004. Epub 2012 Feb 6. Cell Immunol. 2012. PMID: 22370222

8

Direct demonstration of CD4 T cell cooperation in the primary in vivo generation of CD4 effector T cells.

Kroeger DR, Rudulier CD, Peters NC, Bretscher PA. Kroeger DR, et al. Among authors: rudulier cd. Int Immunol. 2012 Aug;24(8):519-27. doi: 10.1093/intimm/dxs055. Epub 2012 Apr 22. Int Immunol. 2012. PMID: 22527289

9

The number of responding CD4 T cells and the dose of antigen conjointly determine the TH1/TH2 phenotype by modulating B7/CD28 interactions.

Rudulier CD, McKinstry KK, Al-Yassin GA, Kroeger DR, Bretscher PA. Rudulier CD, et al. J Immunol. 2014 Jun 1;192(11):5140-50. doi: 10.4049/jimmunol.1301691. Epub 2014 Apr 21. J Immunol. 2014. PMID: 24752446

10

Distinct roles of dendritic and B cells in the activation of naive CD4+ T cells.

Rudulier CD, Kroeger DR, Bretscher PA. Rudulier CD, et al. Immunotherapy. 2012 Apr;4(4):355-7. doi: 10.2217/imt.12.17. Immunotherapy. 2012. PMID: 22512626 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page